[go: up one dir, main page]

MX2007005523A - Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias. - Google Patents

Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias.

Info

Publication number
MX2007005523A
MX2007005523A MX2007005523A MX2007005523A MX2007005523A MX 2007005523 A MX2007005523 A MX 2007005523A MX 2007005523 A MX2007005523 A MX 2007005523A MX 2007005523 A MX2007005523 A MX 2007005523A MX 2007005523 A MX2007005523 A MX 2007005523A
Authority
MX
Mexico
Prior art keywords
allergy
allergen
preventive treatment
subject
mucosal administration
Prior art date
Application number
MX2007005523A
Other languages
English (en)
Inventor
Jens Brimnes
Jens Kildsgaard
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007005523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of MX2007005523A publication Critical patent/MX2007005523A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invencion se refiere a un metodo para el tratamiento preventivo de alergias a un alergeno en un sujeto, que comprende administrar una vacuna contra alergias que contiene al alergeno como sustancia activa a una superficie mucosa del sujeto, a) en donde el sujeto a ser tratado es sensibilizado para de esta manera exhibir una respuesta de IgE especifica contra el alergeno, b) en donde el sujeto a ser tratado esta libre de sintomas clinicos de la alergia asociada con el alergeno y c) en donde el tratamiento preventivo se enfoca a prevenir o reducir sintomas clinicos subsecuentes de la alergia asociada con el alergeno.
MX2007005523A 2004-11-10 2005-11-08 Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias. MX2007005523A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62645404P 2004-11-10 2004-11-10
DKPA200401730 2004-11-10
US68691405P 2005-06-03 2005-06-03
PCT/DK2005/000716 WO2006050729A2 (en) 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Publications (1)

Publication Number Publication Date
MX2007005523A true MX2007005523A (es) 2007-07-05

Family

ID=35840082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005523A MX2007005523A (es) 2004-11-10 2005-11-08 Metodo para el tratamiento preventivo de alergias mediante administracion en mucosas de una vacuna contra alergias.

Country Status (10)

Country Link
US (1) US20060121064A1 (es)
EP (1) EP1812059B1 (es)
JP (1) JP5628473B2 (es)
AT (1) ATE468135T1 (es)
AU (1) AU2005304107B2 (es)
CA (1) CA2586283A1 (es)
DE (1) DE602005021388D1 (es)
MX (1) MX2007005523A (es)
PL (1) PL1812059T3 (es)
WO (1) WO2006050729A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006310881B2 (en) * 2005-11-04 2012-07-19 Alk-Abello A/S Use of a liquid allergy vaccine formulation for oromucosal administration
CN101909646A (zh) * 2008-01-08 2010-12-08 阿尔克-阿贝洛有限公司 用于粘膜施用的过敏症疫苗组合物
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
US8802056B2 (en) * 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
US10080810B2 (en) 2008-07-17 2018-09-25 John Shea Method for testing and treating delayed food allergies
US9724271B2 (en) 2010-04-30 2017-08-08 Allovate, Llc Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
EP2563316B1 (en) * 2010-04-30 2019-02-13 Allovate, LLC Toothpaste for allergic desensitization via the oral mucosa
US20120100163A1 (en) * 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
KR20130118884A (ko) * 2010-10-15 2013-10-30 알크-아벨로 에이/에스 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
CN110531059A (zh) * 2019-09-27 2019-12-03 中国海洋大学 一种食物过敏原动态消化模型和体外模拟评价方法
US20240042017A1 (en) * 2021-02-02 2024-02-08 My-Or Diagnostics Ltd. Methods for preventing oral sensitization
CN115735854B (zh) * 2022-11-15 2025-02-11 中国农业大学 一种榛子食物过敏的动物模型构建方法
WO2024256749A1 (en) 2023-06-12 2024-12-19 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159324A (ja) * 1986-12-22 1988-07-02 Lion Corp スギ花粉症用経口ワクチン
AUPM307793A0 (en) * 1993-12-22 1994-01-20 Holt, Patrick G Professor Prophylaxis of allergic disease
JPH09315998A (ja) * 1996-05-30 1997-12-09 Japan Tobacco Inc スギ花粉症の予防および／または治療剤
CN1338947B (zh) * 1999-02-05 2012-11-14 爱尔开-阿贝优公司 粘膜递送系统
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
WO2003096869A2 (en) * 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Also Published As

Publication number Publication date
EP1812059A2 (en) 2007-08-01
JP2008519776A (ja) 2008-06-12
DE602005021388D1 (de) 2010-07-01
PL1812059T3 (pl) 2010-10-29
HK1108568A1 (en) 2008-05-09
AU2005304107B2 (en) 2011-06-02
CA2586283A1 (en) 2006-05-18
AU2005304107A1 (en) 2006-05-18
US20060121064A1 (en) 2006-06-08
JP5628473B2 (ja) 2014-11-19
EP1812059B1 (en) 2010-05-19
WO2006050729A3 (en) 2006-08-24
WO2006050729A2 (en) 2006-05-18
ATE468135T1 (de) 2010-06-15

Similar Documents

Publication Publication Date Title
PL1812059T3 (pl) Profilaktyka alergii przez podanie na błonę śluzową szczepionki przeciw alergii
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
WO2010030180A3 (en) Peptide formulations and uses thereof
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2006116731A3 (en) Personal care compositions comprising a dipeptide
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
MX2007004882A (es) Derivados de xantina con actividad de receptor de hm74a.
EA201391701A1 (ru) Назальные тестостероновые гели с контролируемым высвобождением, способы перназального введения и предварительно заполненные многодозные аппликаторные системы для перназального введения
MA32872B1 (fr) Traitement du diabete chez des patients dont la regulation glycemique est insuffisante malgre une therapie par un medicament antidiabetique oralou non oral
EA201100506A1 (ru) Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином
WO2007136845A3 (en) Low-dose doxepin for treatment of sleep disorders in elderly patients
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
ATE407690T1 (de) Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen
EA201170484A1 (ru) Терапевтический режим лечения гепатита, включающий пэг-интерферон, рибавирин и vx-950
GB2456475A (en) Composition for the treatment of skin conditions
UA99094C2 (ru) Способ лечения пациента с системной красной волчанкой
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
ATE484292T1 (de) Chorionic gonadotropin zur behandlung des chronischen schmerzsyndroms des beckens
SE0401631L (sv) Ny sammansättning
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
WO2011028799A3 (en) Ganglioside transmucosal formulations
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)

Legal Events

Date Code Title Description
FG Grant or registration